Safety Profile of Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis: Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials
JAMA Dermatol 2022 May 11;[EPub Ahead of Print], KB Gordon, RG Langley, RB Warren, Y Okubo, L Stein Gold, JF Merola, L Peterson, K Wixted, N Cross, D Deherder, D ThaçiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.